Fat cell metabolism: Insulin, fatty acids, and renin

Bray GA: Health hazards of obesity. Endocrinol Metab Clin North Am 1996, 25:907–919. Jensen MD, Haymond MW, Rizza RA, et al.: Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 1989, 83:1168–1173. Jones JP, Dohm GL: Regulation of glucose transporter GLUT-4 and hexokinase II gene transcription by insulin and epinephrine. Am J Physiol 1997, 273:E682-E687. Cornelius P, MacDougald OA, Lane MD: Regulation of adipocyte development. Annu Rev Nutr 1994, 14:99–129. Braissant O, Foufelle F, Scotto C, et al.: Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 1996, 137:354–366. Freytag SO, Paielli DL, Gilbert JD: Ectopic expression of the CCAAT-enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev 1994, 8:1654–1663. Lin FT, Lane MD: CCAAT-enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc Natl Acad Sci USA 1994, 91:8757–8761. Hu E, Tontonoz P, Spiegelman BM: Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha. Proc Natl Acad Sci USA 1995, 92:9856–9860. Yeh WC, Cao Z, Classon M, McKnight SL: Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev 1995, 9:168–181. Tanaka T, Yoshida N, Kishimoto T, Akira S: Defective adipocyte differentiation in mice lacking the C/EBP and C/EBP gene. EMBO J 1997, 16:7432–7443. El-Jack AK, Hamm HK, Pilch PF, Farmer SR: Reconstitution of insulin-sensitive glucose transport in fibroblasts requires expression of both PPARg and C/EBP. J Biol Chem 1999, 274:7946–7951. Stevenson RW, Lreutter DK, Andrews KM, et al.: Possibility of distinct insulin-signaling pathways beyond phosphatidylinositol 3-kinase-mediating glucose transport and lipogenesis. Diabetes 1998, 47:179–185. Berger J, Bailey P, Biswas C, et al.: Thiazolidinediones produce a conformational change in peroxisomal proliferatoractivated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology 1996, 137:4189–4195. Berger J, Leibowitz MD, Doebber TW, et al.: Novel peroxisome proliferator-activated receptor (PPAR) and PPAR ligands produce distinct biological effects. J Biol Chem 1999, 274:6718–6725. Tontonoz P, Hu E, Graves RA, et al.: mPPAR gamma 2: tissuespecific regulator of an adipocyte enhancer. Genes Dev 1994, 8:1224–1234. Schoonjans K, Peinado-Onsurbe J, Lefebvre AM, et al.: PPAR alpha and PPAR gamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J 1996, 15:5336–5348. Tontonoz P, Hu E, Devine J, et al.: PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol 1995, 15:351–357. Kotchen TA, Zhang HY, Reddy SR, Hoffman RG: Effect of pioglitazone on vascular reactivity in vivo and in vitro. Am J Physiol 1996, 270:R660-R666. Nishio E, Watanabe Y: Troglitazone inhibits 1-adrenoceptorinduced DNA synthesis in vascular smooth muscle cells. Eur J Pharmacol 1999, 374:127–135. Yoshimoto T, Naruse M, Shizume H, et al.: Vasculo-protective effects of insulin sensitizing agent pioglitazone in neointimal thickening and hypertensive vascular hypertrophy. Atherosclerosis 1999, 145:333–340. Saleh J, Snider AD, Cianflone K: Regulation of plasma fatty acid metabolism. Clin Chim Acta 1999, 286:163–180. Berk PD, Zhou SL, Kiang CL, et al.: Selective up-regulation of fatty acid uptake by adipocytes characterizes both genetic and diet-induced obesity in rodents. J Biol Chem 1999, 274:28626–28631. This article demonstrates that the obese phenotype is associated with selective upregulation of the fatty acid transporter on adipocytes. Aitman TJ, Glazier AM, Wallace CA, et al.: Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 1999, 21:76–83. This article suggests that the fatty acid transporter, Cd36, is linked to insulin resistance and hypertension. Gotoda T, Lizuka Y, Osuga K, et al.: Absence of Cd36 mutation in the original spontaneously hypertensive rats with insulin resistance. Nat Genet 1999, 22:226–228. Febbraio M, Abumrad NA, Hajjar DP, et al.: A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 1999, 27:19055–19062. This article demonstrates the significance of Cd36 in the uptake of fatty acids by adipocytes. Frohnert BI, Hui TY, Bernlorh DA: Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene. J Biol Chem 1999, 274:3970–3977. Chen G, Koyama K, Yuan X, et al.: Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy. Proc Natl Acad Sci USA 1996, 93:14795–14799. Wang M, Lee Y, Unger R: Novel form of lipolysis induced by leptin. J Biol Chem 1999, 274:17541–17544. This article suggests that adipocytes respond to leptin by stimulating lipolysis, without the concomitant release of fatty acids into the circulation. Zhou Y, Wang Z, Higa M, et al.: Reversing adipocyte differentiation: implications for treatment of obesity. Proc Natl Acad Sci USA 1999, 96:2391–2395. Shek EW, Brands MW, Hall JE: Chronic leptin infusion increases arterial pressure. Hypertension 1998, 31:409–414. Haynes WG, Morgan DA, Walsh SA, et al.: Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997, 100:270–278. Phillips MI, Speakman EA, Kimura B: Levels of angiotensin and molecular biology of tissue renin angiotensin systems. Regul Pept 1993, 43:1–20. Cassis LA, Fettinger M, Shenoy U: Characterization and regulation of angiotensin II receptors in rat adipose tissue. Cell Mol Asp of Angio Rec 1996, 5:39–47. Cassis LA., Laughter A, Fettinger M, et al.: Cold exposure regulates the renin-angiotensin system. J Pharmacol Exp Ther 1998, 286(suppl 2):718–726. Crandall DL, Armellino DC, Busler DE, et al.: Angiotensin II receptors in human preadipocytes: role in cell cycle regulation. Endocrinology 1999, 140(suppl 1):154–158. Cassis LA, Saye J, Peach MJ: Location and regulation of rat angiotensinogen messenger RNA. Hypertension 1988, 11:591–596. This article demonstrates the presence of the angiotensinogen gene in brown and white adipose tissue. Saye J, Ragsdale V, Carey R, Peach M: Localization of angiotensin peptide-forming enzymes of 3T3-F442A adipocytes. Amer J Physiol 1993, 264:C1570-C1576. Safanova I, Aubert J, Negreal R, Ailhaud G: Regulation by fatty acids of angiotensinogen gene expression in preadipose cells. Biochem J 1997, 322(suppl 1):235–239. Aubert J, Darimont C, Safanova I, et al.: Regulation by glucocorticoids of angiotensinogen gene expression and secretion in adipose cells. Biochem J 1997, 328:701–706. Aubert J, Safonova I, Negrel R, Aihaud G: Insulin downregulates angiotensinogen gene expression and angiotensinogen secretion in cultured adipose cells. Biochem Biophys Res Commun 1998, 250(suppl 1):77–82. Frederich R, Kahn B, Peach M, Flier J: Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension 1992, 19:339–344. This article was the first to demonstrate differences in adipose angiotensinogen gene expression with the obese phenotype. Jones BH, Standridge MK, Taylor JW, Moustaid N: Angiotensinogen gene expression in adipose tissue: analysis of obese models and hormonal and nutritional control. Amer J Physiol 1997, 273:236–242. Shenoy U, Cassis L: Characterization of renin activity in brown adipose tissue. Amer J Physiol 1997, 272:989–999. Saye J, Ragsdale V, Carey R, Peach M: Localization of angiotensin peptide-forming enzymes of 3T3-F442A adipocytes. Amer J Physiol 1993, 264:C1570-C1576. Schling P, Mallow H, Trindl A, Loffler G: Evidence for a local renin-angiotensin system in primary cultured human preadipocytes. Int J Obes Relat Metab Disord 1999, 23:336–341. Jones BH, Standridge MK, Moustaid N: Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells. Endocrinology 1997, 138:1512–1519. English V, Cassis L: Facilitation of sympathetic neurotransmission contributes to angiotensin regulation of body weight. J Neural Transm 1999, 106:631–644. Cassis LA: Role of angiotensin II in brown adipose thermogenesis during cold acclimation. Am J Physiol 1993, 265:E860-E865. Cassis LA: Angiotensin II in brown adipose tissue from young and adult zucker obese and lean rats. Am J Physiol 1994, 266:E453-E458. Cassis LA, Marshall DE, Fettinger MJ, et al.: Mechanisms contributing to angiotensin II regulation of body weight. Amer J Physiol 1998, 274:E867-E876. This article demonstrates that the peptide angiotensin II, which can be produced by adipose tissue, can regulate body weight. Schorr U, Blaschke K, Distler TS, Sharma AM: Relationship between angiotensinogen, leptin and blood pressure in young normotensive men. J Hypertens 1998, 16:1475–1480.